Adult Flu Vaccines 2025-2026
Award Notice Posted
- Solicitation number
- 75D301-25-D-20399
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Awarded
- to Astrazeneca Pharmaceuticals LP
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75D301-25-D-20399 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Atlanta, Georgia 30341, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services has awarded a contract (75D301-25-D-20399) to AstraZeneca Pharmaceuticals LP for Adult Flu Vaccines for the 2025-2026 season. The contract, valued at $9,050,000.00, was awarded on December 30, 2024, and was not subject to any specific set-aside provisions. This award covers the procurement of flu vaccines, likely in preparation for the upcoming influenza season, and represents a significant investment by the CDC in public health immunization efforts.
Notice text
Awarded contract 75D301-25-D-20399 to ASTRAZENECA PHARMACEUTICALS LP for 9050000.00 on 2024-12-30.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Adult Flu Vaccines 2025-2026 | Award Notice | |
| Adult Flu Vaccines 2025-2026 | Award Notice | |
| Adult Flu Vaccines 2025-2026 | Award Notice | |
| This notice | Award Notice | |
| Adult Flu Vaccines 2025-2026 | Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity